Lets hope its more than a cut and paste as below from the last quarterly........no wonder the shorters have made the stock a favourite, billions touted in most announcements, yet nil to show for anything........
In parallel with completing enrolment and treatment of patients in these clinical trials, licensing
activities are ongoing for all three products as part of Starpharma’s DEP® commercialisation
strategy.
Ann: Starpharma partners with UQ to advance DEP radio pipeline, page-13
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
